The role of stem cells in aesthetic surgery: Fact or fiction?

Plastic and Reconstructive Surgery

Volumn 134, Issue 2, 2014, Pages 193-200

  McArdle, Adrian ^a   Senarath Yapa, Kshemendra ^a   Walmsley, Graham G ^a   Hu, Michael ^a   Atashroo, David A ^a   Tevlin, Ruth ^a   Zielins, Elizabeth ^a   Gurtner, Geoffrey C ^a   Wan, Derrick C ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMICS; ESTHETIC SURGERY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HUMAN; LEGAL ASPECT; MARKETING; OUTCOME ASSESSMENT; REJUVENATION; REVIEW; STEM CELL TRANSPLANTATION; UNITED STATES;

COSMETIC TECHNIQUES; EVIDENCE-BASED MEDICINE; HUMANS; MARKETING; OUTCOME ASSESSMENT (HEALTH CARE); REJUVENATION; STEM CELL TRANSPLANTATION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84905461765     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0000000000000404     Document Type: Article

References (62)

1. American Society of Plastic Surgeons. 2012 Plastic Surgery Statistics Report. ASPS National Clearinghouse of Plastic Surgery Procedural Statistics. Available at: http://www. plasticsurgery. org/Documents/news-resources/ statistics/2012-Plastic- Surgery-Statistics/full-plastic-surgery-statistics- report. pdf. Accessed June 2, 2014.
2. Ahn CS, Davis SA, Dabade TS, et al. Cosmetic procedures performed in the United States: A 16-year analysis. Dermatol Surg. 2013;39:1351-1359
3. Housman TS, Hancox JG, Mir MR, et al. What specialties perform the most common outpatient cosmetic procedures in the United States? Dermatol Surg. 2008;34:1-7; discussion 8.
4. Paik AM, Hoppe IC, Pastor CJ. An analysis of leading, lagging, and coincident economic indicators in the United States and its relationship to the volume of plastic surgery procedures performed: An update for 2012. Ann Plast Surg. 2013;71:316-319.
5. Swanson E. The commercialization of plastic surgery. Aesthet Surg J. 2013;33:1065-1068.
6. O'Donnell J. Cosmetic surgery gets cheaper, faster, scarier. USA Today September 14, 2011.
7. Anghileri E, Marconi S, Pignatelli A, et al. Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. Stem Cells Dev. 2008;17:909-916.
8. Cyranoski D. Korean deaths spark inquiry. Nature 2010;468:485.
9. Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations. Ann Rev Cell Dev Biol. 2001;17:387-403.
10. Xu C, Inokuma MS, Denham J, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 2001;19:971-974.
11. Sun N, Panetta NJ, Gupta DM, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 2009;106:15720-1572
12. Wan DC, Wong VW, Longaker MT. Craniofacial reconstruction with induced pluripotent stem cells. J Craniofac Surg. 2012;23:623-626.
13. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001;7:211-228.
14. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295
15. Kordes C, Häussinger D. Hepatic stem cell niches. J Clin Invest. 2013;123:1874-1880
16. Pellettieri J, Sánchez Alvarado A. Cell turnover and adult tissue homeostasis: From humans to planarians. Annu Rev Genet. 2007;41:83-105.
17. Liu S, Zhang H, Duan E. Epidermal development in mammals: Key regulators, signals from beneath, and stem cells. Int J Mol Sci. 2013;14:10869-1089
18. Sinclair K, Yerkovich ST, Chambers DC. Mesenchymal stem cells and the lung. Respirology 2013;18:397-411.
19. Locke M, Windsor J, Dunbar PR. Human adipose-derived stem cells: Isolation, characterization and applications in surgery. ANZ J Surg. 2009;79:235-244.
20. Bourin P, Bunnell BA, Casteilla L, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 2013;15:641-648.
21. Gronthos S, Franklin DM, Leddy HA, et al. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol. 2001;189:54-63.
22. Klein AW, Elson ML. The history of substances for soft tissue augmentation. Dermatol Surg. 2000;26:1096-1105.
23. Coleman SR, Saboeiro AP. Fat grafting to the breast revisited: Safety and efficacy. Plast Reconstr Surg. 2007;119:775-785; discussion 786
24. Fisher C, Grahovac TL, Schafer ME, et al. Comparison of harvest and processing techniques for fat grafting and adipose stem cell isolation. Plast Reconstr Surg. 2013;132:351-361
25. Yoshimura K, Sato K, Aoi K, et al. Cell-assisted lipotransfer for cosmetic breast augmentation: Supportive use of adiposederived stem/stromal cells. Aesthetic Plast Surg. 2008;32:48-55; discussion 56-57.
26. Kølle SF, Fischer-Nielsen A, Mathiasen AB, et al. Enrichment of autologous fat grafts with ex-vivo expanded adipose tissuederived stem cells for graft survival: A randomised placebocontrolled trial. Lancet 2013;382:1113-1120.
27. Peltoniemi HH, Salmi A, Miettinen S, et al. Stem cell enrichment does not warrant a higher graft survival in lipofilling ofthe breast: A prospective comparative study. J Plast Reconstr Aesthet Surg. 2013;66:1494-1503.
28. Tabit CJ, Slack GC, Fan K, et al. Fat grafting versus adiposederived stem cell therapy: Distinguishing indications, techniques, and outcomes. Aesthetic Plast Surg. 2012;36:704-713.
29. Atiyeh BS, Ibrahim AE, Saad DA. Stem cell facelift: Between reality and fiction. Aesthet Surg J. 2013;33:334-338.
30. Locke M, Feisst V, Dunbar PR. Concise review: Human adipose- derived stem cells: Separating promise from clinical need. Stem Cells 2011;29:404-411.
31. Zimmerlin L, Donnenberg AD, Rubin JP, et al. Regenerative therapy and cancer: In vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 2011;17:93-106.
32. Prantl L, Muehlberg F, Navone NM, et al. Adipose tissuederived stem cells promote prostate tumor growth. Prostate 2010;70:1709-1715.
33. Muehlberg FL, Song YH, Krohn A, et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009;30:589-597.
34. Yu JM, Jun ES, Bae YC, et al. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev. 2008;17:463-473.
35. Grisendi G, Bussolari R, Cafarelli L, et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Res. 2010;70:3718-3729.
36. Kucerova L, Altanerova V, Matuskova M, et al. Adipose tissuederived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007;67:6304-6313.
37. Gir P, Oni G, Brown SA, et al. Human adipose stem cells: Current clinical applications. Plast Reconstr Surg. 2012;129:1277-1290.
38. ASAPS/ASPS position statement on stem cells and fat grafting. Aesthet Surg J. 2011;31:716-717.
39. Sánchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003;18:93-103.
40. Amable PR, Carias RB, Teixeira MV, et al. Platelet-rich plasma preparation for regenerative medicine: Optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4:67.
41. Schmidt C. FDA approves first cell therapy for wrinkle-free visage. Nat Biotechnol. 2011;29:674-675.
42. Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies. N Engl J Med. 2006;355:1730-1735.
43. Fekete N, Rojewski MT, Fürst D, et al. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS One 2012;7:e43255.
44. Rubio D, Garcia-Castro J, Martin MC, et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005;65:3035-3039.
45. Fink DW Jr. FDA regulation of stem cell-based products. Science 2009;324:1662-1663.
46. Kawabata K, Kobayashi M, Kusaka-Kikushima A, et al. A new objective histological scale for studying human photoaged skin. Skin Res Technol. 2013;20:155-163.
47. Luebberding S, Krueger N, Kerscher M. Mechanical properties of human skin in vivo: A comparative evaluation in 300 men and women. Skin Res Technol. 2014;20:127-135.
48. Lee JY, Kim YK, Seo JY, et al. Loss of elastic fibers causes skin wrinkles in sun-damaged human skin. J Dermatol Sci. 2008;50:99-107.
49. Liu H, Dang Y, Wang Z, et al. Laser induced collagen remodeling: A comparative study in vivo on mouse model. Lasers Surg Med. 2008;40:13-19.
50. Orringer JS, Kang S, Johnson TM, et al. Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol. 2004;140:1326-1332
51. Kim WS, Park BS, Park SH, et al. Antiwrinkle effect of adipose- derived stem cell: Activation of dermal fibroblast by secretory factors. J Dermatol Sci. 2009;53:96-102.
52. Claudio-da-Silva C, Baptista LS, Carias RB, et al. Autologous mesenchymal stem cells culture from adipose tissue for treatment of facial rhytids (in Portuguese). Rev Col Bras Cir. 2009;36:288-291
53. Pang WW, Price EA, Sahoo D, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci USA 2011;108:20012-20017.
54. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5: 133-139.
55. Lichtman MA, Rowe JM. The relationship of patient age to the pathobiology of the clonal myeloid diseases. Semin Oncol. 2004;31:185-197.
56. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell 2008;132:681-696
57. Lombard DB, Chua KF, Mostoslavsky R, et al. DNA repair, genome stability, and aging. Cell 2005;120:497-512
58. Rossi DJ, Bryder D, Seita J, et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007;447:725-729.
59. Rossi DJ, Seita J, Czechowicz A, et al. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle 2007;6:2371-2376
60. Eaves FF III. Got evidence? Stem cells, bias, and the level of evidence ladder: Commentary on: "ASAPS/ASPS position statement on stem cells and fat grafting". Aesthet Surg J. 2011;31:718-722
61. Eaves FF III, Rohrich RJ. So you want to be an evidencebased plastic surgeon? A lifelong journey. Aesthet Surg J. 2011;31:137-142.
62. Rohrich RJ, Eaves FF III. So you want to be an evidencebased plastic surgeon? A lifelong journey. Plast Reconstr Surg. 2011;127:467-472.